☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Revance Submits Supplemental Biologics License Application for Daxxify to Treat Cervical Dystonia
October 21, 2022
PharmaShots Weekly Snapshots (October 17- 21, 2022)
October 21, 2022
LEO’s Adtralza Receives EC's Approval for the Treatment of Moderate to Severe Atopic Dermatitis
October 21, 2022
Eyenovia Reports Results of MicroLine in P-III Trial for the Treatment of Presbyopia
October 21, 2022
AUM Biosciences to Go Public through Reverse Merger with Mountain Crest for Oncology Therapeutics
October 21, 2022
DePuy (J&J)’s Teligen System Receives the US FDA Approval for User-Centric Procedural Control During Spine Surgery
October 21, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions